BSE Live
Oct 01, 16:01Prev. Close
340.85
Open Price
340.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:57Prev. Close
341.00
Open Price
341.00
Bid Price (Qty.)
346.45 (61)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Biocon (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 600.30 | 600.30 | 600.30 | 600.30 | 600.00 | |
Total Share Capital | 600.30 | 600.30 | 600.30 | 600.30 | 600.00 | |
Reserves and Surplus | 21,042.80 | 19,182.50 | 17,265.70 | 7,831.30 | 6,930.10 | |
Total Reserves and Surplus | 21,043.70 | 19,183.40 | 17,266.60 | 7,832.20 | 6,931.00 | |
Total Shareholders Funds | 21,644.00 | 19,783.70 | 17,866.90 | 8,432.50 | 7,531.00 | |
Minority Interest | 6,068.50 | 5,491.10 | 4,621.90 | 1,037.50 | 880.70 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 12,405.40 | 12,932.40 | 15,290.50 | 3,998.50 | 2,961.60 | |
Deferred Tax Liabilities [Net] | 357.70 | 391.50 | 381.80 | 52.30 | 32.30 | |
Other Long Term Liabilities | 3,727.10 | 1,875.60 | 5,144.50 | 2,953.50 | 2,704.50 | |
Long Term Provisions | 260.80 | 237.60 | 226.50 | 91.70 | 106.20 | |
Total Non-Current Liabilities | 16,751.00 | 15,437.10 | 21,043.30 | 7,096.00 | 5,804.60 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 5,350.10 | 2,797.20 | 2,480.20 | 905.50 | 594.20 | |
Trade Payables | 6,548.70 | 6,272.00 | 3,983.10 | 1,608.50 | 1,513.90 | |
Other Current Liabilities | 2,243.40 | 6,110.10 | 1,898.80 | 1,183.50 | 1,992.60 | |
Short Term Provisions | 191.60 | 179.50 | 148.60 | 130.50 | 109.40 | |
Total Current Liabilities | 14,333.80 | 15,358.80 | 8,510.70 | 3,828.00 | 4,210.10 | |
Total Capital And Liabilities | 58,797.30 | 56,070.70 | 52,042.80 | 20,394.00 | 18,522.30 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 9,312.40 | 7,992.60 | 7,535.10 | 5,944.00 | 5,710.60 | |
Intangible Assets | 5,865.20 | 6,278.60 | 5,796.40 | 598.60 | 626.90 | |
Capital Work-In-Progress | 4,101.70 | 3,985.20 | 2,587.50 | 3,420.30 | 2,253.50 | |
Fixed Assets | 23,686.00 | 22,264.50 | 20,648.50 | 10,653.00 | 9,137.70 | |
Non-Current Investments | 679.70 | 684.10 | 742.30 | 370.20 | 743.20 | |
Deferred Tax Assets [Net] | 257.70 | 317.30 | 301.00 | 293.30 | 307.70 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 1,102.00 | 1,253.20 | 1,880.80 | 668.80 | 706.90 | |
Total Non-Current Assets | 42,511.10 | 40,891.50 | 39,708.80 | 12,011.70 | 10,921.90 | |
CURRENT ASSETS | ||||||
Current Investments | 447.30 | 315.60 | 1,326.50 | 1,217.70 | 1,208.70 | |
Inventories | 4,931.10 | 4,943.90 | 4,243.70 | 2,298.20 | 1,866.60 | |
Trade Receivables | 5,487.90 | 6,230.60 | 3,573.20 | 2,058.20 | 1,217.60 | |
Cash And Cash Equivalents | 4,120.20 | 2,258.70 | 2,400.10 | 1,747.50 | 2,015.40 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 1,299.70 | 1,430.40 | 790.50 | 1,060.70 | 1,292.10 | |
Total Current Assets | 16,286.20 | 15,179.20 | 12,334.00 | 8,382.30 | 7,600.40 | |
Total Assets | 58,797.30 | 56,070.70 | 52,042.80 | 20,394.00 | 18,522.30 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 2,086.50 | 2,594.40 | 1,990.90 | 1,585.00 | 1,588.60 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 593.47 | 593.47 | 593.47 | 593.47 | 593.47 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Non-Current Investments Unquoted Book Value | 60.20 | 646.50 | 592.70 | 303.90 | 436.20 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 447.30 | 315.60 | 444.30 | 251.80 | 623.70 | |
Current Investments Unquoted Book Value | 0.00 | 0.00 | 882.20 | 965.90 | 585.00 |
18.09.2025
18.09.2025
11.09.2025
05.09.2025
19.08.2025
Biocon Standalone June 2025 Net Sales at Rs 537.10 crore, up 5.19% Y-o-Y
08.05.2025
Biocon Consolidated March 2025 Net Sales at Rs 4,417.00 crore, up 12.76% Y-o-Y
08.05.2025
Biocon Standalone March 2025 Net Sales at Rs 643.80 crore, up 20.88% Y-o-Y
31.01.2025
Biocon Consolidated December 2024 Net Sales at Rs 3,821.40 crore, down 3.35% Y-o-Y